|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakagawa K, Tanaka K, Homma Y, Nojiri K,
Kumamoto T, Takeda K and Endo I: Low infiltration of peritumoral
regulatory T cells predicts worse outcome following resection of
colorectal liver metastases. Ann Surg Oncol. 22:180–186. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hou J, Zhou Y, Zheng Y, Fan J, Zhou W, Ng
IO, Sun H, Qin L, Qiu S, Lee JM, et al: Hepatic RIG-I predicts
survival and interferon-alpha therapeutic response in
hepatocellular carcinoma. Cancer Cell. 25:49–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohlsson L, Israelsson A, Öberg Å,
Palmqvist R, Stenlund H, Hammarström ML, Hammarström S and Lindmark
G: Lymph node CEA and MUC2 mRNA as useful predictors of outcome in
colorectal cancer. Int J Cancer. 130:1833–1843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raziee HR, Cardoso R, Seevaratnam R, Mahar
A, Helyer L, Law C and Coburn N: Systematic review of the
predictors of positive margins in gastric cancer surgery and the
effect on survival. Gastric Cancer. 15 Suppl 1:S116–S124. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu T, Lin CM, Cheng SQ, Min J, Li L, Meng
XM, Huang C, Zhang L, Deng ZY and Li J: Pathological bases and
clinical impact of long noncoding RNAs in prostate cancer: A new
budding star. Mol Cancer. 17:1032018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Bajic VB and Zhang Z: On the
classification of long non-coding RNAs. RNA Biol. 10:925–933. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Gejman R, Mahta A, Zhong Y, Rice
KA, Zhou Y, Cheunsuchon P, Louis DN and Klibanski A: Maternally
expressed gene 3, an imprinted noncoding RNA gene, is associated
with meningioma pathogenesis and progression. Cancer Res.
70:2350–2358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu M, Zou C, Pan L, Liang W, Qian H, Xu W,
Jiang P and Zhang X: Long noncoding RNAs in digestive system
cancers: Functional roles, molecular mechanisms, and clinical
implications (Review). Oncol Rep. 36:1207–1218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thomassen I, van Gestel YR, van Ramshorst
B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE and de Hingh IH:
Peritoneal carcinomatosis of gastric origin: A population-based
study on incidence, survival and risk factors. Int J Cancer.
134:622–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen L, Chen L, Wang Y, Jiang X, Xia H and
Zhuang Z: Long noncoding RNA MALAT1 promotes brain metastasis by
inducing epithelial-mesenchymal transition in lung cancer. J
Neurooncol. 121:101–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng HT, Shi DB, Wang YW, Li XX, Xu Y,
Tripathi P, Gu WL, Cai GX and Cai SJ: High expression of lncRNA
MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Int J Clin Exp Pathol. 7:3174–3181. 2014.PubMed/NCBI
|
|
17
|
Liu JH, Chen G, Dang YW, Li CJ and Luo DZ:
Expression and prognostic significance of lncRNA MALAT1 in
pancreatic cancer tissues. Asian Pac J Cancer Prev. 15:2971–2977.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Wu Z, Yuan J, Sun L, Lin L, Huang N,
Bin J, Liao Y and Liao W: Long non-coding RNA MALAT1 promotes
gastric cancer tumorigenicity and metastasis by regulating
vasculogenic mimicry and angiogenesis. Cancer Lett. 395:31–44.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao X, Zhao R, Chen Q, Zhao Y, Zhang B,
Zhang Y, Yu J, Han G, Cao W, Li J and Chen X: MALAT1 might be a
predictive marker of poor prognosis in patients who underwent
radical resection of middle thoracic esophageal squamous cell
carcinoma. Cancer Biomark. 15:717–723. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang JZ, Xiang JJ, Wu LG, Bai YS, Chen ZW,
Yin XQ, Wang Q, Guo WH, Peng Y, Guo H and Xu P: A genetic variant
in long non-coding RNA MALAT1 associated with survival outcome
among patients with advanced lung adenocarcinoma: A survival cohort
analysis. BMC Cancer. 17:1672017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jadaliha M, Zong X, Malakar P, Ray T,
Singh DK, Freier SM, Jensen T, Prasanth SG, Karni R, Ray PS and
Prasanth KV: Functional and prognostic significance of long
non-coding RNA MALAT1 as a metastasis driver in ER negative lymph
node negative breast cancer. Oncotarget. 7:40418–40436. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Zhang Y, Yang T, Zhao W, Wang N,
Li P, Zeng X and Zhang W: Long non-coding RNA MALAT1 for promoting
metastasis and proliferation by acting as a ceRNA of miR-144-3p in
osteosarcoma cells. Oncotarget. 8:59417–59434. 2017.PubMed/NCBI
|
|
23
|
Liu M, Sun W, Liu Y and Dong X: The role
of lncRNA MALAT1 in bone metastasis in patients with non-small cell
lung cancer. Oncol Rep. 36:1679–1685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang TH, Liang LZ, Liu XL, Wu JN, Su K,
Chen JY, Zheng QY, Huang HZ and Liao GQ: Long non-coding RNA MALAT1
interacts with miR-124 and modulates tongue cancer growth by
targeting JAG1. Oncol Rep. 37:2087–2094. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qi Y, Ooi HS, Wu J, Chen J, Zhang X, Tan
S, Yu Q, Li YY, Kang Y, Li H, et al: MALAT1 long ncRNA promotes
gastric cancer metastasis by suppressing PCDH10. Oncotarget.
7:12693–12703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L,
Sun J, Cai J, Qin J, Ren J and Li Q: Resveratrol inhibits invasion
and metastasis of colorectal cancer cells via MALAT1 mediated
Wnt/β-catenin signal pathway. PLoS One. 8:e787002013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deng J, Zhang R, Pan Y, Wang B, Wu L, Jiao
X, Bao T, Hao X and Liang H: Comparison of the staging of regional
lymph nodes using the sixth and seventh editions of the
tumor-node-metastasis (TNM) classification system for the
evaluation of overall survival in gastric cancer patients: Findings
of a case-control analysis involving a single institution in China.
Surgery. 156:64–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tierney JF, Stewart LA, Ghersi D, Burdett
S and Sydes MR: Practical methods for incorporating summary
time-to-event data into meta-analysis. Trials. 8:162007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Williamson PR, Smith CT, Hutton JL and
Marson AG: Aggregate data meta-analysis with time-to-event
outcomes. Stat Med. 21:3337–3351. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang C, Yang L, Wang S, Zhang Z, Yu Y,
Wang M, Cromie M, Gao W and Wang SL: The classic EDCs, phthalate
esters and organochlorines, in relation to abnormal sperm quality:
A systematic review with meta-analysis. Sci Rep. 6:199822016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peters JL, Sutton AJ, Jones DR, Abrams KR
and Rushton L: Contour-enhanced meta-analysis funnel plots help
distinguish publication bias from other causes of asymmetry. J Clin
Epidemiol. 61:991–996. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo F, Sun B, Li H, Xu Y, Liu Y, Liu X, Lu
L, Li J, Wang Q, Wei S, et al: A MALAT1/HIF-2α feedback loop
contributes to arsenite carcinogenesis. Oncotarget. 7:5769–5787.
2016.PubMed/NCBI
|
|
34
|
Li C, Miao R, Liu S, Wan Y, Zhang S, Deng
Y, Bi J, Qu K, Zhang J and Liu C: Down-regulation of miR-146b-5p by
long noncoding RNA MALAT1 in hepatocellular carcinoma promotes
cancer growth and metastasis. Oncotarget. 8:28683–28695.
2017.PubMed/NCBI
|
|
35
|
Pang EJ, Yang R, Fu XB and Liu YF:
Overexpression of long non-coding RNA MALAT1 is correlated with
clinical progression and unfavorable prognosis in pancreatic
cancer. Tumour Biol. 36:2403–2407. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and
Goel A: Metastasis-associated long non-coding RNA drives gastric
cancer development and promotes peritoneal metastasis.
Carcinogenesis. 35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li P, Zhang X, Wang H, Wang L, Liu T, Du
L, Yang Y and Wang C: MALAT1 is associated with poor response to
oxaliplatin-based chemotherapy in colorectal cancer patients and
promotes chemoresistance through EZH2. Mol Cancer Ther. 16:739–751.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yao W, Bai Y, Li Y, Guo L, Zeng P, Wang Y,
Qi B, Liu S, Qin X, Li Y and Zhao B: Upregulation of MALAT-1 and
its association with survival rate and the effect on cell cycle and
migration in patients with esophageal squamous cell carcinoma.
Tumour Biol. 37:4305–4312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang W, Zhu Y, Li S, Chen X, Jiang G, Shen
Z, Qiao Y, Wang L, Zheng P and Zhang Y: Long noncoding RNA MALAT1
promotes malignant development of esophageal squamous cell
carcinoma by targeting β-catenin via Ezh2. Oncotarget.
7:25668–25682. 2016.PubMed/NCBI
|
|
40
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A and
Prasanth KV: Long noncoding RNA MALAT1 controls cell cycle
progression by regulating the expression of oncogenic transcription
factor B-MYB. PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Su L, Chen X, Li P, Cai Q, Yu B,
Liu B, Wu W and Zhu Z: MALAT1 promotes cell proliferation in
gastric cancer by recruiting SF2/ASF. Biomed Pharmacother.
68:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han
Z, Sui H, Tang Y, Wang Y, Liu N, et al: Long non-coding RNA MALAT1
promotes tumour growth and metastasis in colorectal cancer through
binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2
complex. Br J Cancer. 111:736–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhai H, Li XM, Maimaiti A, Chen QJ, Liao
W, Lai HM, Liu F and Yang YN: Prognostic value of long noncoding
RNA MALAT1 in digestive system malignancies. Int J Clin Exp Med.
8:18099–18106. 2015.PubMed/NCBI
|
|
46
|
Xiong Y, Wang J, Zhu H, Liu L and Jiang Y:
Chronic oxymatrine treatment induces resistance and
epithelialmesenchymal transition through targeting the long
non-coding RNA MALAT1 in colorectal cancer cells. Oncol Rep.
39:967–976. 2018.PubMed/NCBI
|
|
47
|
Li Y, Bao C, Gu S, Ye D, Jing F, Fan C,
Jin M and Chen K: Associations between novel genetic variants in
the promoter region of MALAT1 and risk of colorectal cancer.
Oncotarget. 8:92604–92614. 2017.PubMed/NCBI
|
|
48
|
Li Q, Dai Y, Wang F and Hou S:
Differentially expressed long non-coding RNAs and the prognostic
potential in colorectal cancer. Neoplasma. 63:977–983. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hu ZY, Wang XY, Guo WB, Xie LY, Huang YQ,
Liu YP, Xiao LW, Li SN, Zhu HF, Li ZG and Kan H: Long non-coding
RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed
SRSF1 phosphorylation in colorectal cancer cells. Oncotarget.
7:11733–11743. 2016.PubMed/NCBI
|
|
50
|
Liu D, Zhu Y, Pang J, Weng X, Feng X and
Guo Y: Knockdown of long non-coding RNA MALAT1 inhibits growth and
motility of human hepatoma cells via modulation of miR-195. J Cell
Biochem. 119:1368–1380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kidane B, Chadi SA, Kanters S, Colquhoun
PH and Ott MC: Local resection compared with radical resection in
the treatment of T1N0M0 rectal adenocarcinoma: A systematic review
and meta-analysis. Dis Colon Rectum. 58:122–140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y
and Yang K: Up-regulation of long noncoding RNA MALAT1 contributes
to proliferation and metastasis in esophageal squamous cell
carcinoma. J Exp Clin Cancer Res. 34:72015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Huang C, Yu Z, Yang H and Lin Y: Increased
MALAT1 expression predicts poor prognosis in esophageal cancer
patients. Biomed Pharmacother. 83:8–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang
MD, Cai Q, Zhou D, Wang JD and Quan ZW: The lncRNA MALAT1 functions
as a competing endogenous RNA to regulate MCL-1 expression by
sponging miR-363-3p in gallbladder cancer. J Cell Mol Med.
20:2299–2308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: TGF-β-induced upregulation of malat1 promotes bladder
cancer metastasis by associating with suz12. Clin Cancer Res.
20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dong Y, Liang G, Yuan B, Yang C, Gao R and
Zhou X: MALAT1 promotes the proliferation and metastasis of
osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol.
36:1477–1486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Huang NS, Chi YY, Xue JY, Liu MY, Huang S,
Mo M, Zhou SL and Wu J: Long non-coding RNA metastasis associated
in lung adenocarcinoma transcript 1 (MALAT1) interacts with
estrogen receptor and predicted poor survival in breast cancer.
Oncotarget. 7:37957–37965. 2016.PubMed/NCBI
|
|
58
|
Miao Y, Fan R, Chen L and Qian H: Clinical
significance of long non-coding RNA MALAT1 expression in tissue and
serum of breast cancer. Ann Clin Lab Sci. 46:418–424.
2016.PubMed/NCBI
|
|
59
|
Yoshimoto R, Mayeda A, Yoshida M and
Nakagawa S: MALAT1 long non-coding RNA in cancer. Biochim Biophys
Acta. 1859:192–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jiao F, Hu H, Yuan C and Wang L, Jiang W,
Jin Z, Guo Z and Wang L: Elevated expression level of long
noncoding RNA MALAT-1 facilitates cell growth, migration and
invasion in pancreatic cancer. Oncol Rep. 32:2485–2492. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xia H, Chen Q, Chen Y, Ge X, Leng W, Tang
Q, Ren M, Chen L, Yuan D, Zhang Y, et al: The lncRNA MALAT1 is a
novel biomarker for gastric cancer metastasis. Oncotarget.
7:56209–56218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Peng R, Luo C, Guo Q, Cao J, Yang Q, Dong
K, Wang S, Wang K and Song C: Association analyses of genetic
variants in long non-coding RNA MALAT1 with breast cancer
susceptibility and mRNA expression of MALAT1 in Chinese Han
population. Gene. 642:241–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
